Clayton, N.S.; Carter, E.P.; Fearon, A.E.; Heward, J.A.; RodrÃguez Fernández, L.; Boughetane, L.; Wilkes, E.H.; Cutillas, P.R.; Grose, R.P.
HDAC Inhibition Restores Response to HER2-Targeted Therapy in Breast Cancer via PHLDA1 Induction. Int. J. Mol. Sci. 2023, 24, 6228.
https://doi.org/10.3390/ijms24076228
AMA Style
Clayton NS, Carter EP, Fearon AE, Heward JA, RodrÃguez Fernández L, Boughetane L, Wilkes EH, Cutillas PR, Grose RP.
HDAC Inhibition Restores Response to HER2-Targeted Therapy in Breast Cancer via PHLDA1 Induction. International Journal of Molecular Sciences. 2023; 24(7):6228.
https://doi.org/10.3390/ijms24076228
Chicago/Turabian Style
Clayton, Natasha S., Edward P. Carter, Abbie E. Fearon, James A. Heward, LucÃa RodrÃguez Fernández, Lina Boughetane, Edmund H. Wilkes, Pedro R. Cutillas, and Richard P. Grose.
2023. "HDAC Inhibition Restores Response to HER2-Targeted Therapy in Breast Cancer via PHLDA1 Induction" International Journal of Molecular Sciences 24, no. 7: 6228.
https://doi.org/10.3390/ijms24076228
APA Style
Clayton, N. S., Carter, E. P., Fearon, A. E., Heward, J. A., RodrÃguez Fernández, L., Boughetane, L., Wilkes, E. H., Cutillas, P. R., & Grose, R. P.
(2023). HDAC Inhibition Restores Response to HER2-Targeted Therapy in Breast Cancer via PHLDA1 Induction. International Journal of Molecular Sciences, 24(7), 6228.
https://doi.org/10.3390/ijms24076228